Full Length Research Paper
References
|
Baliraine FN, Rosenthal PJ (2011). Prolonged Selection of pfmdr1 Polymorphisms After Treatment of Falciparum Malaria With Artemether-Lumefantrine in Uganda. J. Infect. Dis. 204(7):1120-1124. |
|
|
Baraka V, Tinto H, Valea I, Fitzhenry R, Delgado-Ratto C, Mbonye MK, Erhart A (2015). In vivo selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemether-lumefantrine and dihydroartemisinin-piperaquine in Burkina Faso. Antimicrob. Agents Chemother. 59(1):734-7. |
|
|
Beshir KB, Sutherland CJ, Sawa P, Drakeley CJ, Okell L, Mweresa CK, Bousema T (2013). Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrence. J. Infect. Dis. 208(12):2017-2024. |
|
|
Borrmann S, Sasi P, Mwai L, Bashraheil M, Abdallah A, Muriithi S, Marsh K (2011). Declining responsiveness of Plasmodium falciparum infections to artemisinin-based combination treatments on the Kenyan coast. PLoS ONE 6(11):e26005. |
|
|
Djimdé A, Doumbo OK, Steketee RW, Plowe CV (2015). Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria. Lancet 358(9285):890-891. |
|
|
Dokomajilar C, Nsobya SL, Greenhouse B, Rosenthal PJ, Dorsey G (2006). Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic. Antimicrob. Agents Chemother. 50(5):1893-1895. |
|
|
Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, White NJ (2009). Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 361(5):455-467. |
|
|
Duraisingh MT, Cowman AF (2005). Contribution of the pfmdr1 gene to antimalarial drug-resistance. Acta Trop. 94(3):181-90. |
|
|
Eyase FL, Akala HM, Ingasia L, Cheruiyot A, Omondi A, Okudo C, Johnson JD (2013). The Role of Pfmdr1 and Pfcrt in Changing Chloroquine, Amodiaquine, Mefloquine and Lumefantrine Susceptibility in Western-Kenya P. falciparum Samples during 2008-2011. PLoS ONE 8(5):e64299. |
|
|
Gansané A, Nébié I, Soulama I, Tiono A, Diarra A, Konaté AT, Sirima BS (2009). Change of antimalarial first-line treatment in Burkina Faso in 2005. Bull. Soc. Pathol. Exot. 102(1):31-35. |
|
|
Holmgren G, Gil JP, Ferreira PM, Veiga MI, Obonyo CO, Björkman A (2006). Amodiaquine resistant Plasmodium falciparum malaria in vivo is associated with selection of pfcrt 76T and pfmdr1 86Y. Infect. Genet. Evol. 6(4):309-14. |
|
|
Holmgren G, Hamrin J, Svärd J, Mårtensson A, Gil JP, Björkman A (2007). Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa. Infect. Genet. Evol. 7(5):562-9. |
|
|
Kublin JG, Cortese JF, Njunju EM, Mukadam RAG, Wirima JJ, Kazembe PN, Plowe CV (2003). Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J. Infect. Dis. 187(12):1870-5. |
|
|
Laufer MK, Takala-Harrison S, Dzinjalamala FK, Stine OC, Taylor TE, Plowe CV (2010). Return of chloroquine-susceptible falciparum malaria in Malawi was a re-expansion of diverse susceptible parasites. J. Infect. Dis. 202(5):801-808. |
|
|
Lim P, Alker AP, Khim N, Shah NK, Incardona S, Doung S, Ariey F (2009). Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia. Malar. J. 8:11. |
|
|
Maude RJ, Pontavornpinyo W, Saralamba S, Aguas R, Yeung S, Dondorp AM, White LJ (2009). The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia. Malar. J. 8:31. |
|
|
Mwai L, Ochong E, Abdirahman A, Kiara SM, Ward S, Kokwaro G, Nzila A (2009). Chloroquine resistance before and after its withdrawal in Kenya. Malar. J. 8(1):106. |
|
|
Noedl H, Se Y, Sriwichai S, Schaecher K., Teja-Isavadharm P, Smith B, Chan Thap L (2010). Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast Asia. Clin. Infect. Dis. 51(11):e82-e89. |
|
|
Ranford-Cartwright LC, Taylor J, Umasunthar T, Taylor LH, Babiker HA, Lell B, Kremsner PG (1997). Molecular analysis of recrudescent parasites in a Plasmodium falciparum drug efficacy trial in Gabon. Trans. R. Soc. Trop. Med. Hyg. 91(6):719-724. |
|
|
Rogers WO, Sem R, Tero T, Chim P, Lim P, Muth S, Wongsrichanalai C (2009). Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia. Malar. J. 8(1):10. |
|
|
Siribié M, Diarra A, Tiono AB, Soulama I, Sirima SB (2012). Efficacité de l'artéméther-luméfantrine dans le traitement du paludisme simple de l'enfant en milieu rural au Burkina Faso en 2009. Bull. Soc. Pathol. Exot. 105(3):202-7. |
|
|
Sirima SB, Tiono AB, Gansané A, Diarra A, Ouédraogo A, Konaté AT, Taylor WR (2009). The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum. Malar. J. 8(1):48. |
|
|
Sisowath C, Ferreira PE, Bustamante LY, Dahlström S, Mårtensson A, Björkman A, Gil JP (2007). The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa. Trop. Med. Int. Health 12(6):736-42. |
|
|
Sisowath C, Strömberg J, Mårtensson A, Msellem M, Obondo C, Björkman A, Gil JP (2005). In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem). J. Infect. Dis. 191(6):10141017. |
|
|
Somé AF, Séré YY, Dokomajilar C, Zongo I, Rouamba N, Greenhouse B, Rosenthal PJ (2010). Selection of Known Plasmodium falciparum Resistance-Mediating Polymorphisms by Artemether-Lumefantrine and Amodiaquine- Sulfadoxine-Pyrimethamine but Not Dihydroartemisinin- Piperaquine in Burkina Faso. Antimicrob. Agents Chemother. 54(5):1949-1954. |
|
|
Sondo P, Derra K, Tarnagda Z, Nakanabo SD, Zampa O, Kazienga A, Tinto H (2015). Dynamic of plasmodium falciparum chloroquine resistance transporter gene Pfcrt K76T mutation five years after withdrawal of chloroquine in Burkina Faso. Pan Afr. Med. J. 21:1-4. |
|
|
The Four Artemisinine-Based Combinations (4ABC) Study Group (2011). A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trial. PLoS Medicine 8(11):e1001119. |
|
|
Tinto H, Diallo S, Zongo I, Guiraud I, Valea I, Kazienga A, D'Alessandro U (2014). Effectiveness of artesunate-amodiaquine vs. artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Nanoro, Burkina Faso: a non-inferiority randomised trial. Trop. Med. Int. Health. 19(4):469-75. |
|
|
Tinto H, Guekoun L, Zongo I, Guiguemdé RT, D'Alessandro U, Ouédraogo JB (2008). Chloroquine-resistance molecular markers (Pfcrt T76 and Pfmdr-1 Y86) and amodiaquine resistance in Burkina Faso. Trop. Med. Int. Health 13(2):238-40. |
|
|
Tinto H, Ouédraogo JB, Erhart A, Van Overmeir C, Dujardin J-C, Van Marck E, D'Alessandro U (2003). Relationship between the Pfcrt T76 and the Pfmdr-1 Y86 mutations in Plasmodium falciparum and in vitro/in vivo chloroquine resistance in Burkina Faso, West Africa. Infect. Genet. Evol. 3(4):287-292. |
|
|
Tinto H, Zoungrana EB, Coulibaly SO, Ouedraogo JB, Traoré M, Guiguemde TR, D'Alessandro U (2002). Chloroquine and sulphadoxine-pyrimethamine efficacy for uncomplicated malaria treatment and haematological recovery in children in Bobo-Dioulasso, Burkina Faso during a 3-year period 1998-2000. Trop. Med. Int. Health 7(11): 925-930. |
|
|
World Health Organization (WHO) (2003). Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. Geneva. |
|
|
World Health Organization (WHO) (2006). Guidelines for the Treatment of Malaria 2006 Geneva: WHO. |
|
|
Zongo I, Dorsey G, Rouamba N, Tinto H, Dokomajilar C, Guiguemde RT, Ouedraogo JB (2007). Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial. Lancet 369:491-498. |
|
|
Zwang J, Olliaro P, Barennes H, Bonnet M, Brasseur P, Bukirwa H, Randrianarivelojosia M (2009). Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: A multi-centre analysis. Malar. J. 8(1):203. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
